Addex Therapeutics Ltd

Addex Therapeutics Ltdverified

ADXN

Price:

$6.45

Market Cap:

$6.23M

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaborat...[Read more]

Industry

Biotechnology

IPO Date

2020-02-12

Stock Exchange

NASDAQ

Ticker

ADXN

The PE Ratio as of June 2026 (TTM) for Addex Therapeutics Ltd (ADXN) is -0.72

According to Addex Therapeutics Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -0.72. This represents a change of -26.56% compared to the average of -0.98 of the last 4 quarters.

Addex Therapeutics Ltd (ADXN) Historical PE Ratio (quarterly & annually)

How has ADXN PE Ratio performed in the past?

The mean historical PE Ratio of Addex Therapeutics Ltd over the last ten years is -5.82. The current -0.72 PE Ratio has changed 1.14% with respect to the historical average. Over the past ten years (40 quarters), ADXN's PE Ratio was at its highest in in the March 2018 quarter at 14.35. The PE Ratio was at its lowest in in the June 2016 quarter at -11.96.

Quarterly (TTM)
Annual

Average

-5.82

Median

-2.62

Minimum

-32.43

Maximum

0.80

Addex Therapeutics Ltd (ADXN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Addex Therapeutics Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 258.97%

Maximum Annual PE Ratio = 0.80

Minimum Annual Increase = -345.64%

Minimum Annual PE Ratio = -32.43

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.92-216.09%
20240.80-345.64%
2023-0.3248.20%
2022-0.22-90.51%
2021-2.30-44.25%
2020-4.1341.00%
2019-2.93-90.97%
2018-32.43258.97%
2017-9.0335.50%
2016-6.67-9.37%

Addex Therapeutics Ltd (ADXN) Average PE Ratio

How has ADXN PE Ratio performed in the past?

The current PE Ratio of Addex Therapeutics Ltd (ADXN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.15

5-year avg

-0.59

10-year avg

-5.82

Addex Therapeutics Ltd (ADXN) PE Ratio vs. Peers

How is ADXN’s PE Ratio compared to its peers?

Addex Therapeutics Ltd’s PE Ratio is greater than Cardio Diagnostics Holdings, Inc. (-0.84), greater than Brainstorm Cell Therapeutics Inc. (-0.86), less than Matinas BioPharma Holdings, Inc. (-0.45), greater than Radiopharm Theranostics Limited (-1.58), greater than Impact BioMedical Inc. (-4.90), less than Quoin Pharmaceuticals, Ltd. (-0.70), greater than Alaunos Therapeutics, Inc. (-1.07), greater than NeuroSense Therapeutics Ltd. (-2.87), less than NovaBay Pharmaceuticals, Inc. (0.05), less than Adial Pharmaceuticals, Inc. (-0.53),

Build a custom stock screener for Addex Therapeutics Ltd (ADXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Addex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Addex Therapeutics Ltd (ADXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Addex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Addex Therapeutics Ltd's PE Ratio?

How is the PE Ratio calculated for Addex Therapeutics Ltd (ADXN)?

What is the highest PE Ratio for Addex Therapeutics Ltd (ADXN)?

What is the 3-year average PE Ratio for Addex Therapeutics Ltd (ADXN)?

What is the 5-year average PE Ratio for Addex Therapeutics Ltd (ADXN)?

How does the current PE Ratio for Addex Therapeutics Ltd (ADXN) compare to its historical average?